A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus.

Conditions: SLE Interventions: Drug: APG-2575; Other: Placebo Sponsors: Ascentage Pharma Group Inc.; Suzhou Yasheng Pharmaceutical Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials